These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7528191)

  • 1. WIN 66306, a new neurokinin antagonist produced by an Aspergillus species: fermentation, isolation and physico-chemical properties.
    Barrow CJ; Sedlock DM; Sun HH; Cooper R; Gillum AM
    J Antibiot (Tokyo); 1994 Nov; 47(11):1182-7. PubMed ID: 7528191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure determination, pharmacological evaluation, and structure-activity studies of a new cyclic peptide substance P antagonist containing the new amino acid 3-prenyl-beta-hydroxytyrosine, isolated from Aspergillus flavipes.
    Barrow CJ; Doleman MS; Bobko MA; Cooper R
    J Med Chem; 1994 Feb; 37(3):356-63. PubMed ID: 7508512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WIN 64821, a novel neurokinin antagonist produced by an Aspergillus sp. I. Fermentation and isolation.
    Sedlock DM; Barrow CJ; Brownell JE; Hong A; Gillum AM; Houck DR
    J Antibiot (Tokyo); 1994 Apr; 47(4):391-8. PubMed ID: 7515037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WIN 64821, a novel neurokinin antagonist produced by an Aspergillus sp. II. Biological activity.
    Oleynek JJ; Sedlock DM; Barrow CJ; Appell KC; Casiano F; Haycock D; Ward SJ; Kaplita P; Gillum AM
    J Antibiot (Tokyo); 1994 Apr; 47(4):399-410. PubMed ID: 7515038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WS9326A, a novel tachykinin antagonist isolated from Streptomyces violaceusniger no. 9326. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities.
    Hayashi K; Hashimoto M; Shigematsu N; Nishikawa M; Ezaki M; Yamashita M; Kiyoto S; Okuhara M; Kohsaka M; Imanaka H
    J Antibiot (Tokyo); 1992 Jul; 45(7):1055-63. PubMed ID: 1381343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RES-701-1, a novel and selective endothelin type B receptor antagonist produced by Streptomyces sp. RE-701. I. Characterization of producing strain, fermentation, isolation, physico-chemical and biological properties.
    Morishita Y; Chiba S; Tsukuda E; Tanaka T; Ogawa T; Yamasaki M; Yoshida M; Kawamoto I; Matsuda Y
    J Antibiot (Tokyo); 1994 Mar; 47(3):269-75. PubMed ID: 8175478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterization of GR82334, a tachykinin NK1 receptor antagonist, in the isolated spinal cord of the neonatal rat.
    Guo JZ; Yoshioka K; Zhao FY; Hosoki R; Maehara T; Yanagisawa M; Hagan RM; Otsuka M
    Eur J Pharmacol; 1995 Jul; 281(1):49-54. PubMed ID: 8566116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RES-1149-1 and -2, novel non-peptidic endothelin type B receptor antagonists produced by Aspergillus sp. I. Taxonomy of producing strain, fermentation, isolation, and physico-chemical and biological properties.
    Ogawa T; Ando K; Tanaka T; Uosaki Y; Matsuda Y
    J Antibiot (Tokyo); 1996 Jan; 49(1):1-5. PubMed ID: 8609073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of scyliorhinin I and synthetic scyliorhinin I derivatives at mammalian tachykinin NK1, NK2 and NK3 receptors.
    Patacchini R; Quartara L; Rolka K; Zboinska J; Kupryszewski G; Maggi CA
    Eur J Pharmacol; 1993 Dec; 250(2):311-6. PubMed ID: 7509285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tachykinin receptors in the guinea-pig renal pelvis: activation by exogenous and endogenous tachykinins.
    Maggi CA; Patacchini R; Eglezos A; Quartara L; Giuliani S; Giachetti A
    Br J Pharmacol; 1992 Sep; 107(1):27-33. PubMed ID: 1384907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Both extracellular and transmembrane residues contribute to the species selectivity of the neurokinin-1 receptor antagonist WIN 51708.
    Sachais BS; Krause JE
    Mol Pharmacol; 1994 Jul; 46(1):122-8. PubMed ID: 8058046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WS-7338, new endothelin receptor antagonists isolated from Streptomyces sp. No. 7338. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities.
    Miyata S; Hashimoto M; Masui Y; Ezaki M; Takase S; Nishikawa M; Kiyoto S; Okuhara M; Kohsaka M
    J Antibiot (Tokyo); 1992 Jan; 45(1):74-82. PubMed ID: 1312521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonist.
    Beattie DT; Beresford IJ; Connor HE; Marshall FH; Hawcock AB; Hagan RM; Bowers J; Birch PJ; Ward P
    Br J Pharmacol; 1995 Dec; 116(8):3149-57. PubMed ID: 8719789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WIN 64821, a novel neurokinin antagonist produced by an Aspergillus sp. III. Biosynthetic analogs.
    Popp JL; Musza LL; Barrow CJ; Rudewicz PJ; Houck DR
    J Antibiot (Tokyo); 1994 Apr; 47(4):411-9. PubMed ID: 7515039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A family of depsi-peptide fungal metabolites, as selective and competitive human tachykinin receptor (NK2) antagonists: fermentation, isolation, physico-chemical properties, and biological activity.
    Hedge VR; Puar MS; Dai P; Pu H; Patel M; Anthes JC; Richard C; Terracciano J; Das PR; Gullo V
    J Antibiot (Tokyo); 2001 Feb; 54(2):125-35. PubMed ID: 11302484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RES-701-2, -3 and -4, novel and selective endothelin type B receptor antagonists produced by Streptomyces sp. I. Taxonomy of producing strains, fermentation, isolation, and biochemical properties.
    Ogawa T; Ochiai K; Tanaka T; Tsukuda E; Chiba S; Yano K; Yamasaki M; Yoshida M; Matsuda Y
    J Antibiot (Tokyo); 1995 Nov; 48(11):1213-20. PubMed ID: 8557559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurokinin receptor inhibitors: fermentation, isolation, physico-chemical properties, structure and biological activity.
    Hegde VR; Dai P; Chu M; Patel M; Bryant R; Terracciano J; Das PR; Puar MS
    J Antibiot (Tokyo); 1997 Dec; 50(12):983-91. PubMed ID: 9510903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that tachykinin NK1 and NK2 receptors mediate non-adrenergic non-cholinergic excitation and contraction in the circular muscle of guinea-pig duodenum.
    Zagorodnyuk V; Santicioli P; Maggi CA; Giachetti A
    Br J Pharmacol; 1995 May; 115(2):237-46. PubMed ID: 7545517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in the distribution and characteristics of tachykinin NK1 binding sites between human and guinea pig lung.
    Walsh DA; Salmon M; Featherstone R; Wharton J; Church MK; Polak JM
    Br J Pharmacol; 1994 Dec; 113(4):1407-15. PubMed ID: 7534186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of RP 67580, a tachykinin NK1 receptor antagonist, on a primary afferent-evoked response of ventral roots in the neonatal rat spinal cord.
    Hosoki R; Yanagisawa M; Guo JZ; Yoshioka K; Maehara T; Otsuka M
    Br J Pharmacol; 1994 Dec; 113(4):1141-6. PubMed ID: 7534180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.